According to the AP: Now both the British Medical Journal and the World Health Organization state there is little evidence to support Tamiflu for otherwise healthy people when weighing out the risks vs. benefits. Billions of dollars are spent on this drug that now the scientific community finds has weak support from the literature. The drug is widely prescribed to prevent complications associated with the flu (e.g., pneumonia, hospitalization, etc). The study did find that it cut symptoms by one day, but Tamiflu could increase the virus’s resistance to the drug.
Bottom line: Tamiflu seems like it should be used for the most at-risk individuals and not as freely as it has been (especially with children who are frequently prescribed it at the first suspicion of flu). Sometimes it takes a while to have research filter through to all individual clinics so it’s important for you to be informed so you can ask good questions.